Ironwood Pharma (I76) Ownership - Who Owns Ironwood Pharma?
Ironwood Pharma (I76) Ownership Overview
- 3.82% Insiders
- 16.29% Mutual Funds
- 1.18% Other Institutional Investors
- 19.81% ETFs
- 58.90% Public Companies and Individual Investors
The ownership structure of Ironwood Pharma (DE:I76) stock is a mix of institutional, retail, and individual investors. Approximately 37.28% of the company’s stock is owned by Institutional Investors, 3.82% is owned by Insiders, and 58.90% is owned by Public Companies and Individual Investors.
The ownership structure of Ironwood Pharma (DE:I76) stock is a mix of institutional, retail, and individual investors. Approximately 17.47% of the company’s stock is owned by Institutional Investors, 3.82% is owned by Insiders, and 19.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 16, 2026 | Alexander Denner | $20,530,448 | |
| Feb 24, 2026 | John Minardo | $136,177 | |
| Feb 24, 2026 | Tammi L Gaskins | $80,328 | |
| Feb 24, 2026 | Michael Shetzline | $59,322 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | €224,526 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 9,199,568 | Institution | 5.57% | 31,131,338 |
| Ishares | 8,358,957 | Institution | 5.06% | 28,286,710 |
| Vanguard Index Funds | 6,459,281 | Institution | 3.91% | 21,858,207 |
| Spdr | 4,067,805 | Institution | 2.46% | 13,765,452 |
| Federated Hermes Mdt Series | 2,018,702 | Institution | 1.22% | 6,831,288 |
| Fidelity Salem Street Trust | 1,969,776 | Institution | 1.19% | 6,665,722 |
| Thomas Mccourt | 1,898,838 | Insider | 1.15% | 6,425,668 |
| Vanguard Horizon Funds | 1,833,231 | Institution | 1.11% | 6,203,654 |
| Schwab | 1,808,212 | Institution | 1.09% | 6,118,989 |
| Dfa | 1,665,307 | Institution | 1.01% | 5,635,399 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 6,459,281 | Institution | 3.91% | 21,858,207 |
| Federated Hermes Mdt Series | 2,018,702 | Institution | 1.22% | 6,831,288 |
| Fidelity Salem Street Trust | 1,969,776 | Institution | 1.19% | 6,665,722 |
| Vanguard Horizon Funds | 1,833,231 | Institution | 1.11% | 6,203,654 |
| Fidelity Concord Street Trust | 1,426,387 | Institution | 0.86% | 4,826,894 |
| Vanguard Explorer Fund | 1,403,741 | Institution | 0.85% | 4,750,260 |
| Dfa Investment Dimensions Group Inc | 1,304,026 | Institution | 0.79% | 4,412,824 |
| Blackrock Funds | 1,296,137 | Institution | 0.78% | 4,386,128 |
| Tiaa-cref Funds | 1,239,734 | Institution | 0.75% | 4,195,260 |
| Vanguard Scottsdale Funds | 1,130,210 | Institution | 0.68% | 3,824,631 |
FAQ
Who Owns Ironwood Pharma (DE:I76)?
According to the latest TipRanks data, approximately 1.18% of the company's stock is held by institutional investors, 3.82% is held by insiders, and 58.90% is held by retail investors.
What percentage of Ironwood Pharma (DE:I76) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.18% of Ironwood Pharma (DE:I76) stock is held by institutional investors.
What percentage of Ironwood Pharma (DE:I76) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.90% of Ironwood Pharma (DE:I76) stock is held by retail investors.
Who owns the most shares of Ironwood Pharma (DE:I76)?
Vanguard owns the most shares of Ironwood Pharma (DE:I76).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.